← FDA Drug Approvals (Drugs@FDA)

ACETAMINOPHEN

NDA · New Drug Application · Sponsor: HIKMA · Approved 2022-06-03

Drug application

FDA Application #

NDA206968

Application type

New Drug Application

Brand name

ACETAMINOPHEN

Generic name

ACETAMINOPHEN

Active ingredients

ACETAMINOPHEN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

HIKMA

Manufacturer

Hikma Pharmaceuticals USA Inc.

First approval

2022-06-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown